Related Experiment Videos

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer

Yoon Soo Chang1, Luo Wang, Young-Ah Suh

  • 1Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Box 432, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Oncogene
|July 13, 2004
PubMed

Insights

Hypermethylation of the IGFBP-3 promoter silences gene expression in non-small-cell lung cancer (NSCLC). This epigenetic silencing, mediated by Sp-1/Sp-3 and MeCP2, contributes to tumor progression and can be reversed by demethylating agents.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Insulin-like growth factor-binding protein-3 (IGFBP-3) inhibits non-small-cell lung cancer (NSCLC) cell proliferation by inducing apoptosis.
  • Loss of IGFBP-3 expression is observed in approximately half of stage I NSCLC cases.

Purpose of the Study:

  • To investigate the role of IGFBP-3 promoter hypermethylation in the loss of IGFBP-3 expression in NSCLC.
  • To elucidate the molecular mechanisms underlying IGFBP-3 silencing in NSCLC.

Main Methods:

  • Analysis of IGFBP-3 promoter methylation status in NSCLC cell lines and tumor specimens.
  • Treatment of NSCLC cell lines with 5'-aza-2'-deoxycytidine (5'-aza-dC) to assess promoter demethylation and gene expression restoration.
  • Gel shift and chromatin immunoprecipitation assays to study protein-DNA interactions at the IGFBP-3 promoter.
  • Luciferase reporter assays to evaluate the impact of promoter methylation on transcriptional activity.

Main Results:

  • IGFBP-3 promoter hypermethylation was detected in a significant proportion of NSCLC cell lines and tumors across all stages.
  • Methylation status correlated with reduced IGFBP-3 mRNA and protein levels.
  • 5'-aza-dC treatment partially restored IGFBP-3 expression in some cell lines, indicating epigenetic regulation.
  • Methylation of the Sp-1/Sp-3 binding element affected the binding of Sp-1, MeCP2, and HDAC.
  • MeCP2 overexpression further suppressed the transcriptional activity of the methylated IGFBP-3 promoter.

Conclusions:

  • IGFBP-3 promoter hypermethylation is a common mechanism contributing to IGFBP-3 silencing in NSCLC.
  • MeCP2-mediated interference with Sp-1 transactivation plays a role in the transcriptional defect of IGFBP-3 in NSCLC cells with a methylated promoter.
  • These findings highlight the potential of epigenetic therapies targeting promoter methylation for NSCLC treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...